TAMPA, Fla.--(BUSINESS WIRE)--Two weeks ago, Colorado endured the largest cannabis product recall in the state’s history, highlighting the costly consequences that potentially dangerous pesticides have wrought in the nation’s largest adult-use cannabis industry. Neutra Corp. (OTCQB: NTRR) is working to help end the industry’s pesticides problem once and for all by delivering clean, technological alternatives to growers in the state.
In the last week of December, a prominent cannabis edibles company voluntarily recalled nearly 100,000 packaged products after some tested positive for banned chemical pesticides imidacloprid and myclobutanil. The largest recall of cannabis-infused products in U.S. history, it was also the 15th cannabis recall in Denver in 16 weeks—only the latest spot of trouble in the midst of a recurring issue in the industry.
“The U.S. cannabis industry will continue to face recalls until better alternatives to these harsh chemicals are widely adopted,” said NTRR CEO Chris Brown. “We plan to be a part of the solution.”
NTRR is marketing new, potentially healthier alternatives to harsh chemicals in cannabis cultivation. Alongside joint venture partner Surface to Air Solutions (S2O2), the company offers cannabis growers and other businesses a suite of horticultural products—including a plant stimulant, an air-scrubber and a self-cleaning hard surface treatment—that helps keep plants and surfaces free from mold, powdery mildew, botrytis, and mites. Used together, the suite of products allows healthy plants to thrive without the use of pesticides and fungicides. Some are already in use by growers in the United States and Canada.
With analysts predicting that the U.S. cannabis industry could grow by another six states in 2016, NTRR plans to unveil many new products to capitalize on the historic growth of cannabis throughout North America.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
